CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,995 shares (to pay taxes)
- 4 Open-market sale EVP, Quality & Ethics, and CPL sold 30,608 shares at $10.00 ($306,080)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- 4 Planned sale Director sold 7,086 shares at $8.87 ($62,853)
- EFFECT Other Notice of Effectiveness
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 7,844 shares at $8.65 ($67,831)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes SVP, Bioservices gave up 4,263 shares (to pay taxes)
- 8-K Event Other events
- 4 Shares withheld for taxes SVP, Bioservices gave up 1,167 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 1,249 shares (to pay taxes)
Page 6 of 87 · 1,733 filings